SICRF yields 1.06% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, SICRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SICRF + JNJ for your $10,000?
SimCorp A/S, together with its subsidiaries, provides investment management solutions for asset management, fund management, insurance, life/pension, central banks, asset servicing, treasury, sovereign wealth, and wealth management companies. It provides SimCorp Dimension, an integrated front-to-back investment management solution; SimCorp Sofia, a front-to-back investment management solution for the Italian insurance market; SimCorp Gain, an enterprise data management solution for reference and market data management; and SimCorp Coric, a solution for client communications and reporting automation. The company also offers front office solutions, including asset, alternative investment, order, and compliance manager; and back office solutions comprising settlement, corporate actions, cash and securities, investment accounting, collateral, general ledger, and fund administration manager. In addition, it provides middle office solutions consisting of strategy, risk analysis, and performance manager; and data and reporting solutions, which include client communications, data warehouse manager, reconciliation, and enterprise data manager. The company has operations in North America, Europe, the Middle East, Africa, and the Asia Pacific. SimCorp A/S was founded in 1971 and is headquartered in Copenhagen, Denmark.
Full SICRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.